Dare Bioscience Inc

NASDAQ:DARE   2:23:53 PM EDT
0.93
-0.01 (-0.74%)
Earnings Announcements

Daré Bioscience Reports Q3 Loss Of $0.08 Per Share

Published: 11/10/2022 11:30 GMT
Dare Bioscience Inc (DARE) - DarÉ Bioscience Reports Third Quarter 2022 Financial Results and Provides a Company Update.
Qtrly Loss per Share $0.08.
Q3 Earnings per Share View $-0.12 -- Refinitiv Ibes Data (analyst estimates).
Dare-hrt1: Positive Topline Efficacy Data From Phase 1/2 Clinical Study.
Revenue is expected to be $12.88 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $5.7 Million
Next Quarter EPS Guidance is expected to be -$0.03

More details on our Analysts Page.